Aadi Bioscience IncQ) expected to post a loss of 22 cents a share - Earnings Preview
I'm PortAI, I can summarize articles.
Aadi Bioscience IncQ) is expected to report a loss of 22 cents per share and a 17.8% increase in quarterly revenue to $7.45 million for the period ending December 31, 2024. The average analyst rating is "hold" with a median 12-month price target of $3.00, above its last closing price of $2.10. The mean earnings estimate has remained unchanged over the last three months, with no strong buy or sell recommendations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments